|
|
Cationic oligopeptides having microbicidal activity
What is claimed is: 1. A method for inhibiting microbial growth in an environment susceptible to said microbial growth, said method comprising: administering to said ...
|
|
|
Antibiotic cryptdin peptides and methods of their use
The present invention provides substantially purified cryptdin peptides having a consensus amino acid sequence as follows: X.sub.1 -C-X.sub.2 -C-R-X.sub.3 -C-X.sub.4 -E-X...
|
|
|
Broad spectrum antimicrobial compounds and methods of use
The present invention provides indolicidin analogs, which are tryptophan-rich peptides that have substantially the same amino acid sequence as naturally occurring ...
|
|
|
Protegrins
We claim: 1. A purified and isolated or recombinantly produced compound having the formula: ##STR9## or a pharmaceutically acceptable salt or an N-terminal acylated or C-...
|
|
|
Antibiotic cryptdin peptides and methods of their use
The present invention provides a substantially purified cryptdin peptide having a consensus amino acid sequence: X.sub.1 -C-X.sub.2 -C-R-X.sub.3 -C-X.sub.4 -E-X.sub.5 -C-...
|
|
|
Cyclic peptides having broad spectrum antimicrobial activity
OF THE INVENTION 5.1 Definitions "Peptidomimetic Moiety:" As used herein, "peptidomimetic moiety" refers to an organic molecule that mimics the secondary structure of a ...
|
|
|
Vaccine for cytomegalovirus
What is claimed is: 1. A method for vaccinating a susceptible host to confer humoral immunity to human cytomegalovirus (hCMV), said method comprising inoculating the ...
|
|
|
Compositions and methods for the detection, quantitation and purification of antigen-specific T cells
Methods and compositions are provided for labeling T cells according to the specificity of their antigen receptor. A stable multimeric complex is prepared with major ...
|
|
|
Immuno-reactive peptide CTL epitopes of human cytomegalovirus
OF THE PREFERRED EMBODIMENTS According to one aspect of the present invention, a nonapeptide (9 amino acid peptide) of the sequence NLVPMVATV (pp65.sub.495-503) (SEQ ID ...
|
|
|
CTL epitope analogs
Accordingly, this invention comprises a method of producing a human cytomegalovirus peptide cytotoxic T lymphocyte epitope analog with improved immunogenic potency and ...
|
Drugs 
